Filing Details

Accession Number:
0000950170-23-043013
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-16 16:15:34
Reporting Period:
2023-08-15
Accepted Time:
2023-08-16 16:15:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1816736 Disc Medicine Inc. IRON Pharmaceutical Preparations (2834) 851613057
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1951852 Jacob William Savage C/O Disc Medicine, Inc.
321 Arsenal Street, Suite 101
Watertown MA 02472
Chief Medical Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-08-15 3,708 $52.27 3,964 No 4 S Direct
Common Stock Disposition 2023-08-15 2,125 $53.26 1,839 No 4 S Direct
Common Stock Disposition 2023-08-15 1,839 $53.96 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 16, 2023.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.70 to $52.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.75 to $53.74, inclusive.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.78 to $54.13, inclusive.